Diazepam-mediated inhibition of human immunodeficiency virus type 1 expression in human brain cells

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 11, 1997, Pages 2566-2569

  Lokensgard, James R ^a   Gekker, Genya ^a   Hu, Shuxian ^a   Arthur, Andrew F ^a   Chao, Chun C ^a,b   Peterson, Phillip K ^a,b  

^a MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4' CHLORODIAZEPAM; 7 CHLORO 1,3 DIHYDRO 5 (2 PYRROLYL) 2H 1,4 BENZODIAZEPIN 2 ONE; BENZODIAZEPINE DERIVATIVE; CLONAZEPAM; DIAZEPAM; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; R 14458; RO 4864; RO 5247420; UNCLASSIFIED DRUG;

ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; NERVE CELL CULTURE; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS INHIBITION;

EID: 0030726760     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.11.2566     Document Type: Article

References (36)

1. Bachelerie, F., J. Alcami, F. Arenzana-Seisdedos, and J. L. Virelizier. 1991. HIV enhancer activity perpetuated by NF-kappa B induction on infection of monocytes. Nature 350:709-712.
2. Baldessarini, R. J. 1996. Drugs and the treatment of psychiatric disorders: psychosis and anxiety, p. 399-430. In J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Rudden, and A. Goodman Gilman (ed.), Goodman and Gilman's The Pharmacological Basis of Therapeutics. McGraw-Hill, New York, N.Y.
3. Bender, A. S., and L. Hertz. 1987. Pharmacological characteristics of diazepam receptors in neurons and astrocytes in primary cultures. J. Neurosci. Res. 18:366-372.
4. Bessler, H., R. Weizman, M. Gavish, I. Notti, and M. Djaldetti. 1992. Immunomodulatory effect of peripheral benzodiazepine receptor ligands on human mononuclear cells. J. Neuroimmunol. 38:19-25.
5. Braestrup, C., and R. F. Squires. 1977. Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H) diazepam binding. Proc. Natl. Acad. Sci. USA 74:3805-3809.
6. Budka, H. 1986. Multinucleated giant cells in the brain: a hallmark of the acquired immunodeficiency syndrome (AIDS). Acta Neuropathol. 69:253-256.
7. Canat, X., P. Carayon, M. Bouaboula, D. Cahard, D. Shire, C. Roque, and G. Le Fur. 1993. Distribution profile and properties of peripheral-type benzodiazepine receptors on human hemopoietic cells. Life Sci. 52:107-118.
8. Chao, C. C., G. Gekker, S. Hu, and P. K. Peterson. 1994. Human microglial cell defense against Toxoplasma gondii: the role of cytokines. J. Immunol. 152:1246-1252.
9. Cheng-Mayer, C., and J. Levy. 1988. Distinct biological and serological properties of human immunodeficiency viruses from the brain. Ann. Neurol. 23(Suppl.):S58-S61.
10. Dickson, D. W. 1986. Multinucleated giant cells in acquired immunodeficiency syndrome: origin from endogenous microglia? Acta Pathol. Lab. Med. 110:967-968.
11. Drugan, R. C. 1994. Are the nonmitochondrial peripheral benzodiazepine receptors on leukocytes a novel intermediary of brain, behavior, and immunity? Lab. Invest. 70:1-5.
12. Dunne, A. L., H. Siregar, J. Mills, and S. M. Crowe. 1994. HIV replication in chronically infected macrophages is not inhibited by the Tat inhibitors Ro-5-3335 and Ro-24-7429. J. Leukocyte Biol. 56:369-373.
13. Giri, A. K., and S. Banerjee. 1996. Genetic toxicology of four commonly used benzodiazepines: a review. Mutat. Res. 340:93-108.
14. He, J., Y. Chen, M. Farzan, H. Choe, A. Ohagen, S. Gartner, J. Busciglio, X. Yang, W. Hofmann, W. Newman, C. R. Mackay, J. Sodroski, and D. Gabuzda. 1997. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385:645-649.
15. Hsu, M.-C., and S. Tam. 1993. A new approach to antiviral chemotherapy: intervention in viral gene expression by Tat antagonists, p. 153-177. In J. Adams and V. J. Merluzzi (ed.), The search for antiviral drugs. Birkhauser, Boston, Mass.
16. Itzhak, Y., L. Baker, and M. D. Norenberg. 1993. Characterization of the peripheral-type benzodiazepine receptors in cultured astrocytes: evidence for multiplicity. Glia 9:211-218.
17. Jacqué, J.-M., B. Fernández, F. Arenzana-Seisdedos, D. Thomas, F. Baleux, J.-L. Virelizier, and F. Bachelerie. 1996. Permanent occupancy of the human immunodeficiency virus type 1 enhancer by NF-κB is needed for persistent viral replication in monocytes. J. Virol. 70:2930-2938.
18. Koenig, S., H. E. Gendelman, J. M. Orenstein, M. C. Dal Canto, G. H. Pezeshkpour, M. Yungbluth, F. Janotta, A. Aksamit, M. A. Martin, and A. S. Fauci. 1986. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233:1089-1093.
19. Le Fur, G., M. L. Perrier, N. Vaucher, F. Imbault, A. Flamier, J. Benavides, A. Uzan, C. Renault, M. C. Dubroeucq, and C. Gueremy. 1983. Peripheral benzodiazepine binding sites: effect of PK 11195, I-(2-chlorophenyl)-N-methyl-N-(I-methylpropyl)-3-isoquinolinecarboxamide. I. In vitro studies. Life Sci. 32:1839-1847.
20. SF162 expression in acutely infected human brain cell cultures. J. Immunol. 158:2449-2455.
21. Matsumoto, T., M. Ogata, K. Koga, and A. Shigematsu. 1994. Effect of peripheral benzodiazepine receptor ligands on lipopolysaccharide-induced tumor necrosis factor activity in thioglycolate-treated mice. Antimicrob. Agents Chemother. 38:812-816.
22. Mohler, H., and T. Okada. 1977. Benzodiazepine receptor: demonstration in the central nervous system. Science 198:849-851.
23. Oh, Y. J., J. W. Francis, G. J. Markelonis, and T. H. Oh. 1992. Interleukin-I-beta and tumor necrosis factor-alpha increase peripheral-type benzodiazepine binding sites in cultured polygonal astrocytes. J. Neurocnem. 58:2131-2138.
24. Park, C. H., E. Carboni, P. L. Wood, and K. W. Gee. 1996. Characterization of peripheral benzodiazepine type sites in a cultured murine BV-2 microglial cell line. Glia 16:65-70.
25. Pauwels, R. 1993. Discovery of TIBO, a new family of HIV-1-specific reverse transcriptase inhibitors, p. 71-104. In J. Adams and V. J. Merluzzi (ed.), The search for antiviral drugs. Birkhauser, Boston, Mass.
26. Paya, C. V., R. M. Ten, C. Bessia, J. Alcami, R. T. Hay, and J. L. Virelizier. 1992. NF-kappa B-dependent induction of the NF-kappa B p50 subunit gene promoter underlies self-perpetuation of human immunodeficiency virus transcription in monocytic cells. Proc. Natl. Acad. Sci. USA 89:7826-7830.
27. Peterson, P. K., G. Gekker, S. Hu, W. R. Anderson, F. Kravitz, P. S. Portoghese, H. H. J. Balfour, and C. C. Chao. 1994. Morphine amplifies HIV-I expression in chronically infected promonocytes cocultured with human brain cells. J. Neuroimmunol. 50:167-175.
28. Price, R. W., B. Brew, J. J. Sidtis, M. Rosenblum, A. C. Scheck, and P. Cleary. 1988. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 239:586-592.
29. Roulston, A., P. Beauparlant, N. Rice, and J. Hiscott. 1993. Chronic human immunodeficiency virus type 1 infection stimulates distinct NF-κB/rel DNA binding activities in myelomonoblastic cells. J. Virol. 67:5235-5246.
30. Roulston, A., R. Lin, P. Beauparlant, M. A. Wainberg, and J. Hiscott. 1995. Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-κB/Rel transcription factors. Microbiol. Rev. 59:481-505.
31. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17:6419.
32. Squires, R. F., and C. Braestrup. 1977. Benzodiazepine receptors in rat brain. Nature 266:732-734.
33. Suzan, M., D. Salaun, C. Neuveut, B. Spire, I. Hirsch, P. Le Bouteiller, G. Querat, and J. Sire. 1991. Induction of NF-κB during monocyte differentiation by HIV type 1 infection. J. Immunol. 146:377-383.
34. Watkins, B. A., H. H. Dom, W. B. Kelly, R. C. Armstrong, B. J. Potts, F. Ntchaels, C. V. Kufta, and M. Dubois-Dalcq. 1990. Specific tropism of HIV-1 for microglial cells in primary human brain cultures. Science 249:549-553.
35. Zavala, F., J. Haumont, and M. Lenfant. 1985. Interaction of benzodiazepines with mouse macrophages. Eur. J. Pharmacol. 106:561-566.
36. Zavala, F., V. Taupin, and B. Descamps-Latscha. 1990. In vivo treatment with benzodiazepines inhibits murine phagocyte oxidative metabolism and production of interleukin 1, tumor necrosis factor and interleukin 6. J. Pharmacol. Exp. Ther. 255:442-450.